Total Funding
68
70
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
162947
Elphogene is a biotechnological company providing tools and services for liquid-biopsy testing in cancer.
Marek Minarik: CEOPast Role: Genomac International, CEO
About the Company
Elphogene provides a molecular oncomonitor for the detection of cancer progression and treatment monitoring. It is a diagnostic tool based on liquid biopsy screening of ctDNA in the peripheral blood of cancer patients. It is to follow-up with patients in advanced stages of cancer for early detection of newly arising metastatic lesions.
